IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES IDIQ CONTRACT. POP 9/27/21-9/26/26. NTE $3.5 MILLION.

NIH RePORTER · NIH · N01 · $32,796 · view on reporter.nih.gov ↗

Abstract

The Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA) supports research and development of new medications for the treatment of drug addiction. Medication development involves in vitro evaluations, nonclinical pharmacology and toxicology studies, pharmaceutical development, and clinical evaluation of new medications for treating addiction.

Key facts

NIH application ID: 10937509
Project number: 75N95021D00025-P00006-9999-3
Recipient: SRI INTERNATIONAL
Principal Investigator: LALITHA V IYER
Activity code: N01
Funding institute: NIH
Fiscal year: 2023
Award amount: $32,796
Award type: —
Project period: 2021-09-27 → 2026-09-26